Marshall Wace, LLP Tela Bio, Inc. Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Tela Bio, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 106,804 shares of TELA stock, worth $305,459. This represents 0.0% of its overall portfolio holdings.
Number of Shares
106,804Holding current value
$305,459% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TELA
# of Institutions
55Shares Held
18.3MCall Options Held
759KPut Options Held
100-
Essex Woodlands Management, Inc. The Woodlands, TX4.11MShares$11.8 Million2.98% of portfolio
-
Aigh Capital Management LLC Baltimore, MD2.47MShares$7.06 Million2.52% of portfolio
-
Orbimed Advisors LLC San Diego, CA2.16MShares$6.18 Million0.13% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.92MShares$5.48 Million0.29% of portfolio
-
Silverarc Capital Management, LLC1.12MShares$3.22 Million0.71% of portfolio
About TELA Bio, Inc.
- Ticker TELA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 19,157,600
- Market Cap $54.8M
- Description
- TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...